Skip to content
  • News
  • Anal Cancer
  • Bladder Cancer
  • Bone Cancer
  • Brain Cancer
  • Breast Cancer
  • Cancer of Unknown Primary
  • Cervical Cancer
  • Colon Cancer
  • Esophageal Cancer
  • Gastric Cancer
  • GIST
  • Head & Neck Cancer
  • Hodgkins Lymphoma
  • Leukemia
    • Acute Leukemia
    • Chronic Lymphocytic Leukemia
    • Chronic Myeloid Leukemia
  • Liver Cancer
  • Lung Cancer
  • Melanoma
  • Mesothelioma
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • MPN-PV-ET-MF
  • Neuroblastoma
  • Neuroendocrine Tumors
  • Non Hodgkins Lymphoma
  • Ovarian Cancer
  • Pancreatic Cancer
  • Prostate Cancer
  • Renal Cancer
  • Rectal Cancer
  • Sarcoma
  • Skin Care
  • Skin Cancer
  • Testicular Cancer
  • Thyroid Cancer
  • Triple Negative Breast Cancer
  • Uterine Cancer
  • About Us
  • Advertising
  • News
  • Newly Diagnosed
  • Treatment & Care
  • Survivorship
  • Join the Community
  • Newsletter

Chronic Lymphocytic Leukemia

Welcome to the Cancer Connect Leukemia Resource Center and Community. Our goal is to bring patients, caregivers, advocates and experts together in a single community where individuals benefit from expert-authored news and educational programming alongside a robust social network.

  • Pirtobrutinib (Jaypirca) Improves Outcomes for Chronic Lymphocytic Leukemia
    December 19, 2025

    Pirtobrutinib (Jaypirca) Improves Outcomes for Chronic Lymphocytic Leukemia

    Dr. C H Weaver MD
  • Novel Triplet Therapy Induces Rapid Undetectable MRD Responses in CLL
    January 16, 2024

    Novel Triplet Therapy Induces Rapid Undetectable MRD Responses in CLL

    Dr. C H Weaver MD
  • Copiktra: Promising New Treatment for Lymphoma and Chronic Lymphocytic Leukemia
    May 6, 2022

    Copiktra: Promising New Treatment for Lymphoma and Chronic Lymphocytic Leukemia

    Dr. C H Weaver MD
  • Imbruvica® Effective in Newly Diagnosed & Recurrent Chronic Lymphocytic Leukemia
    April 19, 2021

    Imbruvica® Effective in Newly Diagnosed & Recurrent Chronic Lymphocytic Leukemia

    Dr. C H Weaver MD
  • FDA Approves Aliqopa for Relapsed Follicular Lymphoma & CLL
    April 13, 2021

    FDA Approves Aliqopa for Relapsed Follicular Lymphoma & CLL

    Dr. C H Weaver MD
  • The Leukemia Community – Connect With Other Leukemia Patients
    December 10, 2020

    The Leukemia Community – Connect With Other Leukemia Patients

    Dr. C H Weaver MD
  • Brukinsa BTK Inhibitor for CLL/SLL
    July 2, 2020

    Brukinsa BTK Inhibitor for CLL/SLL

    Dr. C H Weaver MD
  • Venclexta Combination Treatment for Chronic Lymphocytic Leukemia
    June 30, 2020

    Venclexta Combination Treatment for Chronic Lymphocytic Leukemia

    Dr. C H Weaver MD
  • Vecabrutinib for Chronic Lymphocytic Leukemia (CLL)
    April 9, 2020

    Vecabrutinib for Chronic Lymphocytic Leukemia (CLL)

    Dr. C H Weaver MD
  • Arzerra™ Treatment for Chronic Lymphocytic Leukemia
    January 21, 2020

    Arzerra™ Treatment for Chronic Lymphocytic Leukemia

    Dr. C H Weaver MD
  • Jaypirca in Chronic Lymphocytic Leukemia and Lymphomas
    January 12, 2020

    Jaypirca in Chronic Lymphocytic Leukemia and Lymphomas

    Dr. C H Weaver MD
  • Calquence Treatment Improves Survival in Chronic Lymphocytic Leukemia
    December 7, 2019

    Calquence Treatment Improves Survival in Chronic Lymphocytic Leukemia

    Dr. C H Weaver MD
1 2
Next Page
  • Sitemap
  • About Us
  • Advertising
  • Privacy Policy

Loading Comments...